Bladder Cancer: A Major Public Health Issue

Slides:

Advertisements

Similar presentations

Pascal Rischmann European Urology Supplements

Advertisements

The Origin of the Bone Scan as a Tumour Marker in Prostate Cancer

Volume 70, Issue 1, Pages (July 2016)

Prostate Cancer 2008: Challenges in Diagnosis and Management

2004 World Health Organization Classification of the Noninvasive Urothelial Neoplasms: Inherent Problems and Clinical Reflections Rodolfo Montironi,

Management of Acute and Chronic Retention in Men

Histologic Grading of Noninvasive Papillary Urothelial Neoplasms

Epidemiology, Staging, Grading, and Risk Stratification of Bladder Cancer Marc Colombel, Mark Soloway, Hideyuki Akaza, Andreas Böhle, Joan Palou, Roger.

Tet Yap, Nicholas Watkin, Suks Minhas European Urology Supplements

Volume 71, Issue 6, Pages e171-e172 (June 2017)

Bladder Cancer: Management and Future Directions

Martin C. Michel European Urology Supplements

Epidemiology, Staging, Grading, and Risk Stratification of Bladder Cancer Marc Colombel, Mark Soloway, Hideyuki Akaza, Andreas Böhle, Joan Palou, Roger.

Treatment of Advanced and Metastatic Renal Cancer: A Revolution?

The Global Risk of Bladder Cancer: Let's Just Do Something About It!

What is New in Bladder Cancer Diagnosis and Management?

The Importance of Transurethral Resection in Managing Patients With Urothelial Cancer in the Bladder: Proposal for a Transurethral Resection of Bladder.

Long-Term Management of Overactive Bladder with Antimuscarinic Agents

A Novel Treatment of Premature Ejaculation

Volume 70, Issue 1, Pages (July 2016)

International Society of Urological Pathology Grading and Other Prognostic Factors for Renal Neoplasia Brett Delahunt, John R. Srigley, Lars Egevad,

Counselling the Prostate Cancer Patient

Volume 56, Issue 6, Pages (December 2009)

Laurent Boccon-Gibod European Urology Supplements

Molecular Tumour Profiling for Detection of Biomarkers in Renal Cell Tumours Kerstin Junker, Jimsgene Sanjmyatav, Joerg Mueller, Thomas Steiner, Heiko.

Human Papilloma Virus, Histopathological, and Molecular Subtyping in Penile Cancer: Relevance for Prognosis and Therapy Kerstin Junker, Sebastian Hölters,

The Origin of the Bone Scan as a Tumour Marker in Prostate Cancer

Current Status of Combined Radiation Therapy and Androgen Suppression in Locally Advanced Prostate Cancer: What Is the Way Forward? Michel Bolla European.

An Update of Current Practice in Hypospadias Surgery

Long-term Cancer-specific Survival in Patients with High-risk, Non–muscle-invasive Bladder Cancer and Tumour Progression: A Systematic Review Sven van.

Richard C. Harkaway European Urology Supplements

Volume 50, Issue 5, Pages (November 2006)

Volume 55, Issue 6, Pages (June 2009)

Optimal Control of Testosterone: A Clinical Case-Based Approach of Modern Androgen- Deprivation Therapy Bertrand Tombal, Richard Berges European Urology.

The Importance of Testosterone Control in Prostate Cancer

Bone Health in Patients With Prostate Cancer: Monitoring and Diagnosis

Testicular Cancer Variations in Time and Space in Europe

Jacques Irani European Urology Supplements

Insights into the Relationships between Prostatic Disorders and Their Potential Impact on Future Urologic Practice Claus Roehrborn European Urology.

Neal Shore European Urology Supplements

The Hallmarks of BPH Progression and Risk Factors

Sergio Bracarda European Urology Supplements

Challenges and Opportunities in Hormone-Resistant Prostate Cancer

Christian Stief European Urology Supplements

Bisphosphonates Can Prevent Skeletal Complications of Malignant Bone Disease from Prostate Cancer and Renal Cell Carcinoma Fred Saad European Urology.

New Trends in Managing the Prostate Cancer Patient

Improving Outcomes in Prostate Cancer: Time to Tackle Bone Disorders

A Multidisciplinary Team Approach for the Optimal Clinical Management of Metastatic Hormone-Refractory Prostate Cancer—Case Study John Fitzpatrick European.

Prostate Cancer 2008: Challenges in Diagnosis and Management

Improving Flexibility and Quality of Life for Your Patients: A Must?

Profile of Silodosin European Urology Supplements

New Concepts in Epidemiology of Lower Urinary Tract Symptoms in Men

The Increasing Responsibility of the Urologist in Maintaining Bone Health in Prostate Cancer Patients Kurt Miller European Urology Supplements Volume.

Prognostic Factors in Non–Muscle-Invasive Bladder Tumors

Beyond Skeletal-Related Events

Treatment Options in Prostate Cancer Once Primary Therapy Fails

Early Single-Instillation Chemotherapy Has No Real Benefit and Should Be Abandoned in Non–Muscle-Invasive Bladder Cancer Sten Holmäng European Urology.

Clinical Management of Patients Receiving Tyrosine Kinase Inhibitors for Advanced Renal Cell Carcinoma Jan Roigas European Urology Supplements Volume.

Volume 43, Issue 1, Pages (January 2003)

Joaquim Bellmunt European Urology Supplements

Classification of Mixed Incontinence

The Impact of Premature Ejaculation on Partners and Relationships

Emmanuel Chartier-Kastler, Andrea Tubaro European Urology Supplements

Epidemiology and Demographics of Prostatitis

New Research Findings on Clinical Benefits of Bisphosphonates in Patients With Advanced Prostate Cancer Noel W. Clarke European Urology Supplements

Jan Roigas European Urology Supplements

Does PSA Testing Influence the Natural History of Prostate Cancer?

Pathology and Molecular Pathogenesis of Renal Cell Carcinoma

Volume 54, Issue 1, Pages (July 2008)

Michael Marberger European Urology Supplements

Presentation transcript:

Bladder Cancer: A Major Public Health Issue Marco Grasso European Urology Supplements Volume 7, Issue 7, Pages 510-515 (July 2008) DOI: 10.1016/j.eursup.2008.04.001 Copyright © 2008 European Association of Urology Terms and Conditions

Fig. 1 Age standardised incidence of bladder cancer in men (data from Kirkali et al [1]). European Urology Supplements 2008 7, 510-515DOI: (10.1016/j.eursup.2008.04.001) Copyright © 2008 European Association of Urology Terms and Conditions

Fig. 2 Low-grade papillary bladder tumour. Image courtesy of Pathology Department, Desio Hospital. European Urology Supplements 2008 7, 510-515DOI: (10.1016/j.eursup.2008.04.001) Copyright © 2008 European Association of Urology Terms and Conditions

Fig. 3 Bladder carcinoma in situ. Image courtesy of Pathology Department, Desio Hospital. European Urology Supplements 2008 7, 510-515DOI: (10.1016/j.eursup.2008.04.001) Copyright © 2008 European Association of Urology Terms and Conditions

Fig. 4 Muscle-invasive bladder cancer. Image courtesy of Pathology Department, Desio Hospital. European Urology Supplements 2008 7, 510-515DOI: (10.1016/j.eursup.2008.04.001) Copyright © 2008 European Association of Urology Terms and Conditions